Better investment decisions begin with better judgement.

For family offices, private banks, institutional investors and investment committees.

Should we allocate capital here?

You recognise that healthcare is changing. The question is whether precision health and women's health deserve a strategic allocation, and if they do, how to gain exposure with institutional discipline rather than thematic enthusiasm.

Together we explore questions such as:

• —Is this a structural investment opportunity or a passing theme?
• —Where does it fit within a long-term portfolio?
• —What is the most appropriate route to the opportunity?
• —How should managers be evaluated?
• —What governance and diligence questions should be addressed before allocating capital?

For specialist healthcare fund managers and established healthcare businesses.

How do we become investable?

Having a compelling strategy or clinically meaningful product is rarely enough. Sophisticated investors allocate capital when they understand the opportunity, believe the evidence, and have confidence in the team and execution.

I help organisations strengthen:

• —institutional positioning
• —investor narrative
• —capital readiness
• —fundraising strategy
• —diligence preparation
• —strategic positioning before important investor or partnership conversations.

For healthcare providers, corporates, insurers, pharmaceutical companies, medtech businesses and healthcare systems.

How should we position ourselves?

Healthcare markets are evolving rapidly. New clinical models, changing demographics and advances in precision medicine are creating opportunities that many organisations recognise but have not yet translated into strategy.

I work with leadership teams to clarify:

• —where these shifts create commercial opportunity
• —how to build category leadership
• —partnership and ecosystem strategy
• —executive positioning
• —growth priorities for the next stage of development.

For foundations, governments, ecosystem organisations and catalytic-capital initiatives.

How do we unlock capital?

Many important healthcare innovations fail to scale because the pathway between early support and commercial investment has not yet been built.

I help organisations explore how research, philanthropy, catalytic capital and commercial investment can work together to create investable markets.